buy medicine online indiamedicine online

    Imatinib mesylate

    Information about Imatinib mesylate

    Imatinib mesylate uses

    Imatinib mesylate is used in the treatment of blood cancer (Chronic myeloid leukaemia) and gastrointestinal stromal tumour.

    How imatinib mesylate works

    Imatinib mesylate is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

    Common side effects of imatinib mesylate

    Nausea, Rash, Vomiting, Musculoskeletal (bone, muscle or joint) pain, Edema, Abdominal pain, Fatigue, Diarrhoea, Muscle cramp

    Available Medicine for Imatinib mesylate

    • ₹849 to ₹2027
      Natco Pharma Ltd
      2 variant(s)
    • ₹49 to ₹4028
      Dr Reddy's Laboratories Ltd
      5 variant(s)
    • ₹752 to ₹2239
      Intas Pharmaceuticals Ltd
      2 variant(s)
    • ₹460 to ₹1644
      Biochem Pharmaceutical Industries
      2 variant(s)
    • ₹752 to ₹2337
      Cipla Ltd
      2 variant(s)
    • ₹900 to ₹2650
      Celon Laboratories Ltd
      2 variant(s)
    • ₹904 to ₹3262
      Zuventus Healthcare Ltd
      2 variant(s)
    • ₹915 to ₹2500
      Sun Pharmaceutical Industries Ltd
      2 variant(s)
    • ₹926 to ₹2004
      Lupin Ltd
      2 variant(s)
    • ₹965 to ₹1813
      Sun Pharmaceutical Industries Ltd
      3 variant(s)

    Expert advice for Imatinib mesylate

    • Always take Imatinib mesylate with food and a full glass of water.
    • Do not change the dose or discontinue use without consulting your doctor.
    • Imatinib mesylate may cause dizziness or blurred vision. If this happens to you, do not drive or use machinery.
    • Water retention and swelling are very common side effects of Imatinib mesylate. Notify your doctor if you have unexpected rapid weight gain.
    • Notify your doctor about all the medications you are taking, including over the counter medicines and dietary supplements.


    Content on this page was last updated on 15 February, 2018, by Dr. Varun Gupta (MD Pharmacology)